Intersect ENT Announces Positive Results from the pilot study Novel In-office

Intersect ENT Announces Positive Results from the pilot study Novel In-office ... As the company PROPEL (R) and drift (R) mini-implants in conjunc...


Intersect ENT Announces Positive Results from the pilot study Novel In-office
As the company PROPEL (R) and drift (R) mini-implants in conjunction with sinus surgery used to improve surgical outcomes, are the product of mometasone furoate, an enhanced steroid with anti-inflammatory properties, directly to the sinus lining .. .
Read more at

Leave a Reply